TABLE 2.
Metric | Patent period | Post‐patent | Total |
---|---|---|---|
Per patient values | |||
Total potential net health effects | 0.50 | 0.50 | |
Realized population net health effects | 0.00 | 0.50 | |
Health foregone due to payments to manufacturer | 0.50 | 0.00 | |
Total values accrued over time (undiscounted) | |||
Total potential net health effects | 5000 | 45,000 | 50,000 |
Realized population net health effects | 0 | 45,000 | 45,000 |
Health foregone due to payments to manufacturer | 5000 | 0 | 5000 |
Total values accrued over time (discounted) | |||
Total potential net health effects | 4304 | 10,008 | 14,312 |
Realized population net health effects | 0 | 10,008 | 10,008 |
Health foregone due to payments to manufacturer | 4304 | 0 | 4304 |
Note: All values are net health effects in QALYs.
Abbreviations: k, measure of health opportunity cost; λ, approval norm; QALY, quality‐adjusted life year.